August 24, 2023

Nanjing Leads Biolabs is starting a new clinical trial for a myeloma bi-specific antibody targeting GPRC5D.

July 25, 2023

Roswell Park Cancer Institute investigates changes in myeloma patients' immune cell subsets after non-chemo interventions.

June 13, 2023

Dr. Gunjan L. Shah and her team at MSK in NY are conducting a clinical trial to reverse T-cell exhaustion by pairing antioxidants alongside CAR T-cell therapy.

May 21, 2023

The main goal of the study is to find out if non-chemotherapeutic interventions can improve the immune system and quality of life in people with myeloma.

May 10, 2023

Does sleep apnea cause myeloma to progress? This clinical trial will help us learn more.

April 27, 2023

The UNC invites patients and caregivers to help them understand what factors affect patients' physical/mental health and quality of life.

April 13, 2023

This study evaluates if the addition of isatuximab to the triple combination elotuzumab, pomalidomide and dexamethasone leads to improved response rates.

April 06, 2023

A clinical trial at MSKCC is open to determine if a new agent can enhance PET scans for better myeloma detection.L.

March 29, 2023

A study to understand how best to use daratumumab in newly diagnosed older myeloma patients.

March 21, 2023

A new bispecific antibody called elranatamab is being tested in studies for relapsed and refractory myeloma patients